Navigation Links
PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
Date:5/14/2009

in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Corporation (Nasdaq: RGEN ) today announced that ... to support the ongoing development of new treatments ... (MDA). This grant will support the completion ... of a drug candidate for human clinical trials. ... important funding for Repligen,s research but it also ...
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...
(Date:12/15/2009)... Law Office has announced the launch of several innovative ... legal services in the current economic climate. The ... opportunity to finance legal services over a period of ... equity in their start-up companies. The second is ... montly payment arrangements over 6 to 12 month period ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) announced today that ... has granted CTI,s request to transfer,the listing of its ... NASDAQ,Capital Market, which will be effective with the open ... continue to trade under the ticker symbol,CTIC. , ...
... Inc. (Nasdaq: MEDX ) announced today that it ... Healthcare Conference at 8:30 a.m. Pacific Time (11:30 a.m. Eastern ... webcast live and will be available in the Investor Relations ... archived edition of the presentation will be available following the ...
... that The Michael J. Fox Foundation has awarded it ... collaboration with The Parkinson,s Institute to evaluate Omeros, recent ... Parkinson,s disease. Located in regions of the brain responsible ... its novel target to the treatment of any movement ...
Other Biology Technology:Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 2Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 3Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3
(Date:12/16/2009)... Maryland School of Medicine researcher will lead the coordinating ... scientists in the field of stem cell research. Michael ... was chosen by the National Heart, Lung and Blood ... of national experts, which will be called the NHLBI ... funded by a $30 million grant over seven years. ...
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
(Date:12/16/2009)... REDWOOD SHORES, Calif. and PALM HARBOR, Fla., ... ("CIC") (OTC Bulletin Board: CICI), a leading ... process automation in the financial industry* and ... and Docubase Systems Inc. ("Docubase"), a leading ... announced today that they have entered an ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Announcing ISMPP EU 2010 the First European Meeting of the International Society for Medical Publication Professionals Royal College of Physicians 15171 1Announcing ISMPP EU 2010 the First European Meeting of the International Society for Medical Publication Professionals Royal College of Physicians 15171 2Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 1Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 2Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 3Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 4European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 1European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 2European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 3
... risk of cardiovascular events -- a combined endpoint including ... -- in both men and women, according to a ... Duke University Medical Center cardiologist. , However, the researchers ... between the sexes. For men, aspirin lowered the risk ...
... that transplanted stem cells can regenerate damaged heart muscle in ... an intravenous infusion of adult mesenchymal stem cells from healthy ... tissue. , A unique benefit of the stem cell product ... IV line. Other therapies require delivery to the site ...
... are developing a method to determine in a matter of ... just by looking at the pattern of active genes in ... today at the ASM Biodefense Research Meeting. , "Effective prophylaxis ... rely upon early diagnosis and rapid initiation of therapy. ...
Other Biology News:Aspirin reduces cardiovascular risks in men and women -- but differently 2Aspirin reduces cardiovascular risks in men and women -- but differently 3Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 2Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 3Gene patterns in white blood cells quickly diagnose disease 2
... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
... catalyzes the template-directed polymerization of nucleotides into ... Polymerase I possesses a 3?5 exonuclease activity ... rate during DNA replication, and also contains ... enzyme to replace nucleotides in the growing ...
... is a genetically engineered Klenow polymerase in which ... removed, leaving only the 5 to 3 polymerase ... Klenow Fragment the enzyme of choice for isotopic ... random primed method, and for DNA sequencing by ...
Request Info...
Biology Products: